CCR6 compounds
US-10117865-B2 · Nov 6, 2018 · US
CCR6 compounds
US10786494B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10786494-B2 |
| Application number | US-201816150796-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 3, 2018 |
| Priority date | Dec 2, 2013 |
| Publication date | Sep 29, 2020 |
| Grant date | Sep 29, 2020 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Compounds of formula (I) are provided which are useful in the treatment of diseases or conditions modulated at least in part by CCR6:
First claim
Opening claim text (preview).
What is claimed is: 1. A method of treating psoriasis, comprising administering to a subject in need thereof, a compound selected from the group consisting of, or a pharmaceutically acceptable salt thereof. 2. A method in accordance with claim 1 , wherein the compound is selected from the group consisting of: or a pharmaceutically acceptable salt thereof. 3. A method in accordance with claim 1 , wherein the compound is or a pharmaceutically acceptable salt thereof. 4. A method in accordance with claim 1 , wherein the compound is or a pharmaceutically acceptable salt thereof. 5. A method in accordance with claim 1 , wherein the compound is or a pharmaceutically acceptable salt thereof.
Assignees
Inventors
Classifications
containing further heterocyclic rings · CPC title
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
directly linked by a ring-member-to-ring-member bond · CPC title
for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia · CPC title
Drugs for disorders of the cardiovascular system · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10786494B2 cover?
- Compounds of formula (I) are provided which are useful in the treatment of diseases or conditions modulated at least in part by CCR6:
- Who is the assignee on this patent?
- Chemocentryx Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K31/47. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Sep 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).